Stable patients experienced the lowest increase in non-drug health care spending WASHINGTON – The Institute for Patient Access (IfPA) released a new analysis of commercial health
When it comes to abusing prescription opioids, teenagers want to be lectured. No, really. I have some level of insight on the issue. Several months
Vacation season? Perhaps. But summer hasn’t slowed the Institute for Patient Access’ steady stream of physician-led insight on policy issues that matter to patients and
Cancer patients are being asked to pay more than they expected for treatment, despite having health insurance. And when the out-of-pocket burden becomes unbearable, some
A money-back deal for cholesterol-lowering PCSK9 inhibitors doesn’t cut costs enough, claims a new analysis from a University of Pittsburgh researcher. The drug’s manufacturer says
International prescription drug donation programs make a difference, explains a new white paper from the Global Alliance for Patient Access. But they could work even
The need for robust clinical trials participation is critical to women and men across this country, whether they know it or not. I came to
Video explains how pay-for-value arrangements can improve patients’ access to innovative medicine WASHINGTON – Today the Alliance for Patient Access released a new video, “Understanding
Innovation comes at a price, one that health insurers may hesitate to pay. While some patients reap a benefit from breakthrough drugs, others do not.
Opting for cheaper prescription drugs seems like an obvious way to cut health care costs. The assumption has led health plans to employ utilization management